Evozyne
Arjun Rallapalli is focused on developing Evozyne’s overall strategy by identifying new markets, solutions, and services for the company’s proprietary technology and implementing the strategy through business development and partnerships. Before Evozyne, Arjun was a manager at McKinsey & Company, where he led strategy engagements across different sectors. He began his career at GE Healthcare before obtaining a Ph.D. in electrical engineering at Duke University where he explored the possibility of creating photonic logic devices using DNA and organic molecules.
Evozyne
1 followers
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.